Omnicell, Inc. - Common Stock (NQ:OMCL)

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher...

Topics Stocks

3 Russell 2000 Stocks We Approach with Caution

January 25, 2026

The past six months have been a windfall for Omnicell’s shareholders. The company’s stock price has jumped 80.2%, hitting $50.52 per share. This was partly thanks to its solid quarterly results, and...

3 Reasons to Sell OMCL and 1 Stock to Buy Instead

January 19, 2026

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

3 Small-Cap Stocks We Keep Off Our Radar

January 15, 2026

Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

January 13, 2026

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant...

3 Inflated Stocks with Open Questions

January 11, 2026

The stock has rallied significantly from its 52-week low of $22.66 in May.

Omnicell Executive Trims Holdings in $244,000 Sale as Stock Trades Near 2025 Highs ↗

January 05, 2026

Via The Motley Fool

Topics Regulatory Compliance

1 Cash-Producing Stock with Impressive Fundamentals and 2 We Avoid

December 24, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management

December 08, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the...

1 Healthcare Stock with Impressive Fundamentals and 2 We Brush Off

December 07, 2025

Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show

Topics Stocks

December 01, 2025

Healthcare Technology for Providers Q3 Earnings: Privia Health (NASDAQ:PRVA) is the Best in the Biz

November 25, 2025

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare technology for providers industry, including Privia Health (NASDAQ:PRVA) and its peers.

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

3 Low-Volatility Stocks That Concern Us

November 25, 2025

CooperCompanies, iRhythm, Baxter, Omnicell, and Neogen Shares Skyrocket, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Topics Artificial Intelligence Economy Stocks

Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference

November 20, 2025

Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies

November 13, 2025

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these...

3 Russell 2000 Stocks with Warning Signs

November 06, 2025

The company continues to benefit from demand for its next-generation healthcare tech offerings.

Why Omnicell Stock Crushed the Market Today ↗

October 30, 2025

Via The Motley Fool

Why Omnicell (OMCL) Stock Is Trading Up Today

October 30, 2025

Shares of healthcare tech company Omnicell (NASDAQ:OMCL) jumped 10.9% in the morning session after the company reported strong third-quarter 2025 financial results that beat expectations and raised its...

Omnicell Inc (NASDAQ:OMCL) Surpasses Q3 2025 Estimates, Stock Rises on Strong Guidance ↗

Topics Economy Government World Trade

October 30, 2025

Omnicell (OMCL) Q3 2025 earnings beat estimates, with revenue of $310.6M and non-GAAP EPS of $0.51. The stock rose 8% pre-market on the strong results and raised guidance.

Via Chartmill

Topics Earnings

Omnicell (NASDAQ:OMCL) Reports Bullish Q3, Stock Soars

October 30, 2025

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 10% year on year to $310.6 million. On top of that, next quarter’s...

Omnicell Announces Third Quarter 2025 Financial Results

October 30, 2025

Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Thursday morning. Here’s what you need to know.

Omnicell (OMCL) To Report Earnings Tomorrow: Here Is What To Expect

October 28, 2025

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Topics Artificial Intelligence

3 of Wall Street’s Favorite Stocks That Concern Us

October 27, 2025

Looking back on healthcare technology stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Tandem Diabetes (NASDAQ:TNDM) and its peers.

Healthcare Technology Stocks Q2 Highlights: Tandem Diabetes (NASDAQ:TNDM)

October 26, 2025

Q2 Rundown: Privia Health (NASDAQ:PRVA) Vs Other Healthcare Technology for Providers Stocks

October 20, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare technology for providers stocks fared in Q2,...

Q2 Earnings Highs And Lows: Premier (NASDAQ:PINC) Vs The Rest Of The Healthcare Technology for Providers Stocks

October 14, 2025

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare technology for providers industry, including Premier (NASDAQ:PINC) and its peers.

Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know

Topics Economy

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Topics Economy Government World Trade

Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025

October 06, 2025